By taking control of her health and making healthy changes, Cristal Chora received a kidney transplant and is now able to inspire others in her work as a dietitian.
According to the National Kidney Foundation, 1:7 people in the United States – about 15% of the adult population – have some form of chronic kidney disease.
DaVita and Fresenius account for more than 80% of the U.S. dialysis market, with thousands of brick-and-mortar treatment centers. But new technologies...
Joining previous investors, DaVita Venture Group led an investment round to fund NephroSant’s needle-free urine test that detects allograft rejection following kidney transplantation. The Series A funding round closed at $16 million.
DaVita in the News
September 21, 2020
September 9, 2020